16,814 XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 52,000 | 1,126,666 (6%) | 0% | 0 | Common Stock | |
| Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 66,667 | 1,193,333 (6%) | 0% | 0 | Common Stock | |
| Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 74,000 | 1,074,666 (6%) | 0% | 0 | Common Stock | |
| Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 186,000 | 2,586,598 (14%) | 1% | 0 | Common Stock | |
| Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 141,000 | 2,400,598 (13%) | 0% | 0 | Common Stock | |
| Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 100,000 | 2,686,598 (15%) | 0% | 0 | Common Stock | |
| Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 48,500 | 799,833 (4%) | 0% | 0 | Common Stock | |
| Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 33,334 | 833,167 (4%) | 0% | 0 | Common Stock | |
| Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 45,000 | 751,333 (4%) | 0% | 0 | Common Stock | |
| Avraham Gabay | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 42,000 | 434,040 (2%) | 0% | 0 | Common Stock | |
| Avraham Gabay | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 34,000 | 392,040 (2%) | 0% | 0 | Common Stock | |
| Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 207,000 | 1,000,666 (5%) | 1% | - | Common Stock | |
| Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 433,500 | 2,259,598 (12%) | 2% | - | Common Stock | |
| Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 194,500 | 706,333 (3%) | 1% | - | Common Stock | |
| Avraham Gabay | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 188,000 | 358,040 (2%) | 1% | - | Common Stock | |
| Miriam Kidron | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 30,000 | 793,666 (4%) | 0% | - | Common Stock | |
| Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 45,000 | 1,826,098 (10%) | 0% | - | Common Stock | |
| Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 30,000 | 511,833 (2%) | 0% | - | Common Stock | |
| Avraham Gabay | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 30,000 | 170,040 (0%) | 0% | - | Common Stock | |
| Avraham Gabay | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 140,040 | 0 (0%) | 0% | - | Common Stock | |
| Yehuda Reznick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 760 | 30,560 (0%) | 0% | - | Common Stock | |
| Yehuda Reznick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2024 | 29,800 | 29,800 (0%) | 0% | - | Common Stock | |
| Aghion Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2024 | 3,750 | 38,820 (0%) | 0% | - | Common Stock | |
| Kidron Miriam | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 295,500 | 763,666 (4%) | 1% | - | Common Stock | |
| Aghion Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 30,000 | 30,000 (0%) | 0% | - | Common Stock | |
| David Silberman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 136,500 | 366,500 (2%) | 0% | - | Common Stock | |
| Arie Mayer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 30,000 | 86,809 (0%) | 0% | - | Common Stock | |
| Leonard Sank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 9,325 | 98,021 (0%) | 0% | - | Common Stock | |
| Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 329,000 | 1,781,098 (9%) | 1% | - | Common Stock | |
| Yadin Rozov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 30,000 | 146,500 (0%) | 0% | - | Common Stock | |
| Hexter Joshua | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 180,500 | 481,833 (2%) | 1% | - | Common Stock | |
| Leonard Sank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 30,000 | 88,696 (0%) | 0% | - | Common Stock | |
| Yadin Rozov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 8,820 | 155,320 (0%) | 0% | - | Common Stock | |
| Shapiro Benjamin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 5,070 | 55,070 (0%) | 0% | - | Common Stock | |
| Benjamin Shapiro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 30,000 | 50,000 (0%) | 0% | - | Common Stock | |
| Arie Mayer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 9,325 | 96,134 (0%) | 0% | - | Common Stock | |
| Aghion Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 5,070 | 35,070 (0%) | 0% | - | Common Stock | |
| Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 53,500 | 468,166 (2%) | 0% | - | Common Stock | |
| Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 120,000 | 1,452,098 (8%) | 0% | - | Common Stock | |
| Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 27,000 | 301,333 (1%) | 0% | - | Common Stock | |
| David Silberman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 24,500 | 230,000 (1%) | 0% | - | Common Stock | |
| Netanel Derovan | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 20,500 | 149,500 (0%) | 0% | - | Common Stock | |
| Benjamin Shapiro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 20,000 | 20,000 (0%) | 0% | - | Common Stock | |
| Leonard Sank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 30,000 | 58,696 (0%) | 0% | - | Common Stock | |
| Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 213,000 | 414,666 (2%) | 1% | - | Common Stock | |
| Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 279,000 | 1,332,098 (7%) | 1% | - | Common Stock | |
| Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 108,000 | 274,333 (1%) | 0% | - | Common Stock | |
| Arie Mayer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 30,000 | 56,809 (0%) | 0% | - | Common Stock | |
| David Silberman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 97,500 | 205,500 (1%) | 0% | - | Common Stock | |
| Netanel Derovan | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 81,000 | 129,000 (0%) | 0% | - | Common Stock | |
| Yadin Rozov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 30,000 | 116,500 (0%) | 0% | - | Common Stock | |
| Arie Mayer | Director | Purchase of securities on an exchange or from another person at price $ 2.21 per share. | 03 Apr 2023 | 3,800 | 26,809 (0%) | 0% | 2.2 | 8,398 | Common Stock |
| Arie Mayer | Director | Purchase of securities on an exchange or from another person at price $ 2.22 per share. | 03 Apr 2023 | 5,009 | 23,009 (0%) | 0% | 2.2 | 11,120 | Common Stock |
| Kidron Nadav | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.04 per share. | 16 Mar 2023 | 26,000 | 126,000 (0%) | 0% | 2.0 | 53,014 | Common Stock |
| Miriam Kidron | Director, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 2.01 per share. | 14 Mar 2023 | 100,000 | 201,666 (1%) | 0% | 2.0 | 201,000 | Common Stock |
| Kidron Nadav | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.01 per share. | 14 Mar 2023 | 100,000 | 100,000 (0%) | 0% | 2.0 | 201,000 | Common Stock |
| Yadin Rozov | Director | Purchase of securities on an exchange or from another person at price $ 1.96 per share. | 13 Mar 2023 | 20,000 | 36,500 (0%) | 0% | 2.0 | 39,120 | Common Stock |
| Yadin Rozov | Director | Purchase of securities on an exchange or from another person at price $ 2.05 per share. | 13 Mar 2023 | 50,000 | 86,500 (0%) | 0% | 2.0 | 102,450 | Common Stock |
| Michael Rabinowitz | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 13.01 per share. | 03 Jan 2023 | 1,425 | 138,043 (0%) | 0% | 13.0 | 18,544 | Common Stock |
| Michael Rabinowitz | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 12.49 per share. | 03 Jan 2023 | 11,900 | 126,143 (0%) | 0% | 12.5 | 148,651 | Common Stock |
| Leonard Sank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2022 | 20,000 | 0 | - | - | Stock Option | |
| Leonard Sank | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.77 per share. | 08 Aug 2022 | 9,304 | 28,696 (0%) | 0% | 8.8 | 81,596 | Common Stock |
| Leonard Sank | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.08 per share. | 08 Aug 2022 | 20,000 | 38,000 (0%) | 0% | 4.1 | 81,600 | Common Stock |
| Leonard Sank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 12,000 | 18,000 (0%) | 0% | - | Common Stock | |
| Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 84,000 | 301,666 (1%) | 0% | - | Common Stock | |
| Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 34,000 | 217,666 (1%) | 0% | - | Common Stock | |
| Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 126,000 | 1,090,729 (6%) | 0% | - | Common Stock | |
| Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 34,000 | 964,729 (5%) | 0% | - | Common Stock | |
| Kidron Nadav | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.36 per share. | 28 Jul 2022 | 12,631 | 1,078,098 (6%) | 0% | 8.4 | 105,595 | Common Stock |
| Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 42,000 | 166,333 (0%) | 0% | - | Common Stock | |
| Arie Mayer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 12,000 | 18,000 (0%) | 0% | - | Common Stock | |
| David Silberman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 39,000 | 108,000 (0%) | 0% | - | Common Stock | |
| Michael Rabinowitz | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 30,000 | 139,468 (0%) | 0% | - | Common Stock | |
| Netanel Derovan | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 30,000 | 48,000 (0%) | 0% | - | Common Stock | |
| Yadin Rozov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 12,000 | 16,500 (0%) | 0% | - | Common Stock | |
| Yadin Rozov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 4,500 | 4,500 (0%) | 0% | - | Common Stock | |
| Yadin Rozov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| Kevin Rakin | Director | Sale of securities on an exchange or to another person at price $ 9.41 per share. | 21 Mar 2022 | 10,000 | 46,661 (0%) | 0% | 9.4 | 94,096 | Common Stock |
| Kevin Rakin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.63 per share. | 17 Feb 2022 | 3,010 | 56,661 (0%) | 0% | 10.6 | 31,996 | Common Stock |
| Kevin Rakin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 6,667 | 0 | - | - | Stock Option (right to buy) | |
| Kevin Rakin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.80 per share. | 17 Feb 2022 | 6,667 | 59,671 (0%) | 0% | 4.8 | 32,002 | Common Stock |
| Kevin Rakin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2022 | 5,000 | 53,004 (0%) | 0% | 0 | Common Stock | |
| Netanel Derovan | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2022 | 18,000 | 18,000 (0%) | 0% | - | Common Stock | |
| Netanel Derovan | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Leonard Sank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Leonard Sank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 6,000 | 6,000 (0%) | 0% | - | Common Stock | |
| Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 42,000 | 183,666 (1%) | 0% | - | Common Stock | |
| Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 72,000 | 72,000 | - | - | Stock Option (right to buy) | |
| Kevin Rakin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 6,000 | 58,004 (0%) | 0% | - | Common Stock | |
| Kevin Rakin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 107,000 | 107,000 | - | - | Stock Option (right to buy | |
| Kidron Nadav | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.89 per share. | 03 Jan 2022 | 48,752 | 867,729 (4%) | 0% | 13.9 | 677,165 | Common Stock |
| Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 63,000 | 930,729 (5%) | 0% | - | Common Stock | |
| Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 150,000 | 916,481 (5%) | 0% | - | Common Stock | |
| Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 21,000 | 124,333 (0%) | 0% | - | Common Stock | |
| Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 36,000 | 36,000 | - | - | Stock Option (right to buy) | |
| Aviad Friedman | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jan 2022 | 6,000 | 0 (0%) | 0% | 0 | Common Stock | |
| Aviad Friedman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 6,000 | 6,000 (0%) | 0% | - | Common Stock | |
| Aviad Friedman | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jan 2022 | 10,000 | 0 | - | - | Stock Option (right to buy | |
| Aviad Friedman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,000 | 10,000 | - | - | Stock Option (right to buy | |
| Arie Mayer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 6,000 | 6,000 (0%) | 0% | - | Common Stock | |
| David Silberman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 32,000 | 32,000 | - | - | Stock Option (right to buy) | |
| David Silberman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 19,000 | 69,000 (0%) | 0% | - | Common Stock | |
| Michael Rabinowitz | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 19,000 | 109,468 (0%) | 0% | - | Common Stock | |
| Michael Rabinowitz | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 32,000 | 32,000 | - | - | Stock Option (right to buy) | |
| Kidron Nadav | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Dec 2021 | 20,000 | 766,481 (4%) | 0% | - | Common Stock | |
| Kidron Nadav | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 28 Dec 2021 | 31,728 | 786,481 (4%) | 0% | 13.0 | 411,829 | Common Stock |
| Michael Rabinowitz | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 28 Dec 2021 | 9,532 | 90,468 (0%) | 0% | 13.0 | 123,725 | Common Stock |
| Kevin Rakin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Dec 2021 | 5,000 | 52,004 (0%) | 0% | 0 | Common Stock | |
| Kevin Rakin | Director | Sale of securities on an exchange or to another person at price $ 20.99 per share. | 16 Sep 2021 | 21,100 | 57,004 (0%) | 0% | 21.0 | 442,830 | Common Stock |
| David Silberman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| David Silberman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 50,000 | 50,000 (0%) | 0% | 0 | Common Stock | |
| Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2021 | 66,666 | 141,666 (0%) | 0% | - | Common Stock | |
| Kevin Rakin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2021 | 10,000 | 78,104 (0%) | 0% | - | Common Stock | |
| Kidron Nadav | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2021 | 100,000 | 748,573 (4%) | 0% | - | Common Stock | |
| Joshua Hexter | Chief Operating & BO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2021 | 33,333 | 103,333 (0%) | 0% | - | Common Stock | |
| Aviad Friedman | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Aug 2021 | 10,000 | 0 (0%) | 0% | 0 | Common Stock | |
| Aviad Friedman | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Aug 2021 | 12,191 | 0 (0%) | 0% | 0 | Common Stock | |
| Kevin Rakin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2021 | 5,697 | 0 | - | - | Stock Option (right to buy) | |
| Kevin Rakin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.23 per share. | 09 Aug 2021 | 5,697 | 20,758 (0%) | 0% | 6.2 | 35,492 | Common Stock |
| Kevin Rakin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.09 per share. | 09 Aug 2021 | 1,683 | 19,075 (0%) | 0% | 21.1 | 35,494 | Common Stock |
| Kevin Rakin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.80 per share. | 09 Aug 2021 | 6,666 | 25,741 (0%) | 0% | 4.8 | 31,997 | Common Stock |
| Kevin Rakin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.09 per share. | 09 Aug 2021 | 1,517 | 24,224 (0%) | 0% | 21.1 | 31,994 | Common Stock |
| Kevin Rakin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.17 per share. | 09 Aug 2021 | 10,000 | 34,224 (0%) | 0% | 4.2 | 41,700 | Common Stock |
| Kevin Rakin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.09 per share. | 09 Aug 2021 | 1,977 | 32,247 (0%) | 0% | 21.1 | 41,695 | Common Stock |
| Kevin Rakin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.77 per share. | 09 Aug 2021 | 56,773 | 89,020 (0%) | 0% | 7.8 | 441,126 | Common Stock |
| Kevin Rakin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.09 per share. | 09 Aug 2021 | 20,916 | 68,104 (0%) | 0% | 21.1 | 441,118 | Common Stock |
| Kevin Rakin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2021 | 6,666 | 0 | - | - | Stock Option (right to buy) | |
| Kevin Rakin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2021 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
| Kevin Rakin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2021 | 56,773 | 0 | - | - | Stock Option (right to buy) | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 20.11 per share. | 09 Aug 2021 | 220,000 | 648,573 (3%) | 1% | 20.1 | 4,423,144 | Common Stock |
| Michael Rabinowitz | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2021 | 100,000 | 100,000 (0%) | 0% | 0 | Common Stock | |
| Michael Rabinowitz | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2021 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Leonard Sank | Director | Other type of transaction at price $ 3.68 per share. | 26 Feb 2021 | 78,125 | 0 (0%) | 0% | 3.7 | 287,500 | Common Stock |
| Leonard Sank | Director | Other type of transaction at price $ 3.68 per share. | 26 Feb 2021 | 375,000 | 0 (0%) | 2% | 3.7 | 1,380,000 | Common Stock |
| Kevin Rakin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Joshua Hexter | COO, Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Avraham Gabay | CFO, Treasurer and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Leonard Sank | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2020 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Kevin Rakin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2020 | 190,000 | 190,000 | - | - | Stock Option (right to buy) | |
| Aviad Friedman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Gao Xiaoming | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Arie Mayer | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2019 | 104,000 | 104,000 | - | - | Stock Option (right to buy) | |
| Miriam Kidron | Director, Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Sep 2019 | 104,000 | 0 | - | - | Stock Option (right to buy) | |
| Kevin Rakin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2019 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Kevin Rakin | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Sep 2019 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Sep 2019 | 196,500 | 0 | - | - | Stock Option (right to buy) | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2019 | 196,500 | 196,500 | - | - | Stock Option (right to buy) | |
| Joshua Hexter | Chf. Op. & Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2019 | 100,000 | 100,000 | - | - | Stock option (right to buy) | |
| Avraham Gabay | CFO, Treasurer and Secretary | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Sep 2019 | 33,146 | 0 | - | - | Stock Option (right to buy) | |
| Avraham Gabay | CFO, Treasurer and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2019 | 33,146 | 33,146 | - | - | Stock Option (right to buy) | |
| Leonard Sank | None | Purchase of securities on an exchange or from another person at price $ 2.95 per share. | 09 Sep 2019 | 10,000 | 374,999 (2%) | 0% | 3.0 | 29,500 | Common Stock |
| Leonard Sank | None | Purchase of securities on an exchange or from another person at price $ 2.90 per share. | 09 Sep 2019 | 15,000 | 364,999 (2%) | 0% | 2.9 | 43,500 | Common Stock |
| Leonard Sank | None | Purchase of securities on an exchange or from another person at price $ 3.86 per share. | 16 Jul 2019 | 4,497 | 349,999 (1%) | 0% | 3.9 | 17,336 | Common Stock |
| Leonard Sank | None | Purchase of securities on an exchange or from another person at price $ 3.74 per share. | 16 Jul 2019 | 10,020 | 345,502 (1%) | 0% | 3.7 | 37,497 | Common Stock |
| Leonard Sank | None | Purchase of securities on an exchange or from another person at price $ 3.58 per share. | 16 Jul 2019 | 20,000 | 335,482 (1%) | 0% | 3.6 | 71,562 | Common Stock |
| Leonard Sank | None | Purchase of securities on an exchange or from another person at price $ 3.47 per share. | 16 Jul 2019 | 20,000 | 315,482 (1%) | 0% | 3.5 | 69,316 | Common Stock |
| Leonard Sank | None | Purchase of securities on an exchange or from another person at price $ 3.22 per share. | 11 Jul 2019 | 1,320 | 295,482 (1%) | 0% | 3.2 | 4,250 | Common Stock |
| Avraham Gabay | CFO, Treasurer and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2019 | 33,146 | 33,146 | - | - | Stock Option (right to buy) | |
| David Slager | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2019 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Kevin Rakin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2019 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2019 | 104,000 | 104,000 | - | - | Stock Option (right to buy) | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2019 | 196,500 | 196,500 | - | - | Stock Option (right to buy) | |
| Hilla Eisenberg | CFO, Treasurer and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2019 | 37,000 | 37,000 | - | - | Stock Option (right to buy) | |
| Mark Daniel Hasleton | VP Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2019 | 22,500 | 22,500 | - | - | Stock Option (right to buy) | |
| Aviad Friedman | None | Purchase of securities on an exchange or from another person at price $ 4.82 per share. | 09 Aug 2018 | 500 | 10,191 (0%) | 0% | 4.8 | 2,410 | Common Stock |
| Aviad Friedman | None | Purchase of securities on an exchange or from another person at price $ 4.98 per share. | 09 Aug 2018 | 2,000 | 12,191 (0%) | 0% | 5.0 | 9,960 | Common Stock |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.98 per share. | 10 Jul 2018 | 61 | 958,087 (5%) | 0% | 6.0 | 365 | Common Stock |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.92 per share. | 10 Jul 2018 | 122 | 958,209 (5%) | 0% | 5.9 | 722 | Common Stock |
| Joshua Hexter | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2018 | 30,000 | 30,000 | - | - | Stock option (right to buy) | |
| Joshua Hexter | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2018 | 30,000 | 30,000 | - | - | Stock option (right to buy) | |
| Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2018 | 47,000 | 47,000 | - | - | Stock Option (right to buy) | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2018 | 97,000 | 97,000 | - | - | Stock Option (right to buy) | |
| Hilla Eisenberg | CFO, Treasurer and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2018 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| David Slager | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2017 | 16,892 | 0 | - | - | Warrant (right to buy) | |
| David Slager | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.77 per share. | 31 Oct 2017 | 16,892 | 1,316,328 (9%) | 0% | 3.8 | 63,609 | Common Stock |
| Leonard Sank | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2017 | 5,631 | 0 | - | - | Warrant (right to buy) | |
| Leonard Sank | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2017 | 6,373 | 0 | - | - | Warrant (right to buy) | |
| Leonard Sank | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.00 per share. | 23 Oct 2017 | 5,631 | 287,789 (2%) | 0% | 6 | 33,786 | Common Stock |
| Leonard Sank | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.00 per share. | 23 Oct 2017 | 6,373 | 294,162 (2%) | 0% | 6 | 38,238 | Common Stock |
| David Slager | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.77 per share. | 17 Aug 2017 | 112,613 | 1,299,436 (9%) | 0% | 3.8 | 424,056 | Common Stock |
| David Slager | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2017 | 112,613 | 0 | - | - | Warrant (right to buy) | |
| Leonard Sank | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.00 per share. | 15 Aug 2017 | 11,262 | 282,158 (2%) | 0% | 6 | 67,572 | Common Stock |
| Leonard Sank | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2017 | 11,262 | 0 | - | - | Warrant (right to buy) | |
| Miriam Kidron | Director, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.50 per share. | 02 Aug 2017 | 89,636 | 75,000 (0%) | 0% | 8.5 | 761,906 | Common Stock |
| Xiaopeng Li | None | Purchase of securities on an exchange or from another person at price $ 8.50 per share. | 02 Aug 2017 | 89,636 | 206,350 (1%) | 0% | 8.5 | 761,906 | COMMON STOCK |
| Leonard Sank | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2017 | 16,773 | 16,773 | - | - | Stock Option (right to buy) | |
| Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2017 | 69,999 | 69,999 | - | - | Stock Option (right to buy) | |
| Miriam Kidron | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2017 | 75,000 | 164,636 (1%) | 0% | 0 | Common Stock | |
| Kevin Rakin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2017 | 56,773 | 56,773 | - | - | Stock Option (right to buy) | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2017 | 147,000 | 147,000 | - | - | Stock Option (right to buy) | |
| Yifat Zommer | CFO, Treasurer and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2017 | 20,001 | 20,001 | - | - | Stock Option (right to buy) | |
| Xiaopeng Li | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2017 | 16,773 | 16,773 | - | - | Stock Option (right to buy) | |
| David Slager | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2017 | 16,773 | 16,773 | - | - | Stock Option (right to buy) | |
| Aviad Friedman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2017 | 16,773 | 16,773 | - | - | Stock Option (right to buy) | |
| Miriam Kidron | Director, Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.33 per share. | 19 Apr 2017 | 52,814 | 89,636 (0%) | 0% | 6.3 | 334,313 | Common Stock |
| Xiaopeng Li | None | Purchase of securities on an exchange or from another person at price $ 6.33 per share. | 19 Apr 2017 | 52,814 | 116,714 (0%) | 0% | 6.3 | 334,313 | Common Stock |
| Ronald Edward Law | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2017 | 37,152 | 37,152 | - | - | Stock Option (right to buy) | |
| Kevin Rakin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2017 | 5,697 | 5,697 | - | - | Stock Option (right to buy) | |
| Xiaopeng Li | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2017 | 12,253 | 12,253 | - | - | Stock Option (right to buy) | |
| David Slager | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2017 | 5,697 | 5,697 | - | - | Stock Option (right to buy) | |
| Aviad Friedman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2017 | 4,084 | 4,084 | - | - | Stock Option (right to buy) | |
| Kevin Rakin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2016 | 3,300 | 15,061 | - | - | Common Stock | |
| Kevin Rakin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2016 | 2,300 | 11,761 | - | - | Common Stock | |
| Kevin Rakin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2016 | 7,261 | 9,461 | - | - | Common Stock | |
| Kevin Rakin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2016 | 2,200 | 2,200 | - | - | Common Stock | |
| Xiaopeng Li | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2016 | 63,900 | 63,900 | - | - | Common Stock | |
| Joshua Hexter | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2016 | 70,000 | 70,000 | - | - | Common Stock | |
| Leonard Sank | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2016 | 3,000 | 270,896 | - | - | Common Stock | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 May 2016 | 100 | 958,148 | - | - | Common Stock | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 May 2016 | 300 | 958,048 | - | - | Common Stock | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 May 2016 | 300 | 957,748 | - | - | Common Stock | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 May 2016 | 300 | 957,448 | - | - | Common Stock | |
| Harold Jacob | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 10 Mar 2016 | 8,500 | 16,396 | - | - | Common Stock | |
| Miriam Kidron | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 28 Dec 2015 | 11,000 | 181,450 | - | - | Common Stock | |
| Miriam Kidron | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 28 Dec 2015 | 15,000 | 166,450 | - | - | Common Stock | |
| Miriam Kidron | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 28 Dec 2015 | 24,000 | 142,450 | - | - | Common Stock | |
| Michael Berelowitz | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 09 Dec 2015 | 700 | 22,896 | - | - | Common Stock | |
| Michael Berelowitz | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 07 Dec 2015 | 539 | 24,357 | - | - | Common Stock | |
| Michael Berelowitz | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 07 Dec 2015 | 761 | 23,596 | - | - | Common Stock | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 May 2015 | 200 | 956,748 | - | - | Common Stock | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 May 2015 | 100 | 956,848 | - | - | Common Stock | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 May 2015 | 200 | 957,048 | - | - | Common Stock | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 12 May 2015 | 100 | 957,148 | - | - | Common Stock | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Mar 2015 | 500 | 954,448 | - | - | Common Stock | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Mar 2015 | 500 | 954,948 | - | - | Common Stock | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Mar 2015 | 400 | 955,348 | - | - | Common Stock | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Mar 2015 | 1,100 | 956,448 | - | - | Common Stock | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Mar 2015 | 100 | 956,548 | - | - | Common Stock | |
| Miriam Kidron | Director, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2015 | 79,848 | 192,450 | - | - | Common Stock | |
| Leonard Sank | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2015 | 22,178 | 267,896 | - | - | Common Stock | |
| Yifat Zommer | CFO, Treasurer and Secretary, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2015 | 46,560 | 46,560 | - | - | Common Stock | |
| Harold Jacob | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2015 | 22,178 | 24,896 | - | - | Common Stock | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2015 | 79,848 | 953,948 | - | - | Common Stock | |
| Michael Berelowitz | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2015 | 22,178 | 24,896 | - | - | Common Stock | |
| Gerald M. Ostrov | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2015 | 22,178 | 24,896 | - | - | Common Stock | |
| Miriam Kidron | Director, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2014 | 9,788 | 112,602 | - | - | Common Stock | |
| Leonard Sank | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2014 | 2,718 | 245,718 | - | - | Common Stock | |
| Harold Jacob | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2014 | 2,718 | 2,718 | - | - | Common Stock | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2014 | 9,788 | 874,100 | - | - | Common Stock | |
| Michael Berelowitz | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2014 | 2,718 | 2,718 | - | - | Common Stock | |
| Gerald M. Ostrov | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2014 | 2,718 | 2,718 | - | - | Common Stock | |
| Miriam Kidron | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 10 Sep 2014 | 23,000 | 111,513 | - | - | Common Stock | |
| Miriam Kidron | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 10 Sep 2014 | 8,699 | 102,814 | - | - | Common Stock | |
| Miriam Kidron | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 04 Sep 2014 | 8,301 | 134,513 | - | - | Common Stock | |
| Miriam Kidron | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2014 | 142,814 | 142,814 | - | - | Common Stock | |
| Miriam Kidron | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2014 | 142,814 | 0 | - | - | Warrant (right to buy) | |
| Harold Jacob | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 14 Apr 2014 | 700 | 700 | - | - | Common Stock | |
| Miriam Kidron | Director, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2014 | 47,134 | 47,134 | - | - | Stock Option (right to buy) | |
| Leonard Sank | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2014 | 13,094 | 13,094 | - | - | Stock Option (right to buy) | |
| Harold Jacob | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2014 | 13,094 | 13,094 | - | - | Stock Option (right to buy) | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2014 | 47,134 | 47,134 | - | - | Stock Option (right to buy) | |
| Michael Berelowitz | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2014 | 13,094 | 13,094 | - | - | Stock Option (right to buy) | |
| Gerald M. Ostrov | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2014 | 13,094 | 13,094 | - | - | Stock Option (right to buy) | |
| Miriam Kidron | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2014 | 137,300 | 137,300 | - | - | Common Stock | |
| Miriam Kidron | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 01 Apr 2014 | 137,300 | 0 | - | - | Common Stock | |
| Miriam Kidron | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2014 | 137,300 | 142,814 | - | - | Warrant (right to buy) | |
| Michael Berelowitz | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2014 | 3,334 | 0 | - | - | Stock Option (right to buy) | |
| Michael Berelowitz | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2014 | 6,100 | 18,900 | - | - | Stock Option (right to buy) | |
| Michael Berelowitz | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 31 Mar 2014 | 9,434 | 0 | - | - | Common Stock | |
| Michael Berelowitz | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2014 | 3,334 | 3,334 | - | - | Common Stock | |
| Michael Berelowitz | None | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2014 | 6,100 | 9,434 | - | - | Common Stock | |
| Harold Jacob | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 30 Dec 2013 | 834 | 0 | - | - | Common Stock | |
| Yifat Zommer | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2012 | 609,000 | 609,000 | - | - | Stock Option (right to buy) | |
| Harold Jacob | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2012 | 240,000 | 240,000 | - | - | Stock Option (right to buy) | |
| Leonard Sank | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2011 | 328,125 | 328,125 | - | - | Warrant (right to buy) | |
| Leonard Sank | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 Oct 2011 | 937,500 | 937,500 | - | - | Common Stock | |
| Zeev Bronfeld | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 27 Sep 2011 | 350,000 | 5,808,517 | - | - | Common Stock | |
| Zeev Bronfeld | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Mar 2011 | 273,438 | 273,438 | - | - | Warrant | |
| Zeev Bronfeld | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Mar 2011 | 781,250 | 7,213,205 | - | - | Common Stock | |
| Michael Berelowitz | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2010 | 300,000 | 300,000 | - | - | Stock Option (right to buy) | |
| Miriam Kidron | Director, Chief Medical &Tech Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2010 | 864,000 | 5,939,360 | - | - | Stock Option (right to buy) | |
| Kidron Nadav | Director, CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2010 | 864,000 | 12,949,735 | - | - | Stock Option (right to buy) | |
| Yifat Zommer | CFO, TREASURER AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2009 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| Leonard Sank | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2009 | 300,000 | 300,000 | - | - | Stock Option (right to buy) | |
| Harold Jacob | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2009 | 300,000 | 300,000 | - | - | Stock Option (right to buy) | |
| Chaime Orlev | CFO, Treasurer and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2008 | 828,000 | 828,000 | - | - | Stock Option (right to buy) | |
| Miriam Kidron | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2008 | 864,000 | 864,000 | - | - | Stock Option (right to buy) | |
| Kidron Nadav | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2008 | 864,000 | 864,000 | - | - | Stock Option (right to buy) | |
| Leonard Sank | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Jan 2008 | 15,650 | 3,552,650 | - | - | Common Stock | |
| Leonard Sank | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 15 Jan 2008 | 5,000 | 3,557,650 | - | - | Common Stock | |
| Leonard Sank | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 07 Jan 2008 | 22,840 | 3,537,000 | - | - | Common Stock | |
| Leonard Sank | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2008 | 48,000 | 3,514,160 | - | - | Common Stock | |
| Leonard Sank | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Dec 2007 | 10,000 | 3,260,000 | - | - | Common Stock | |
| Leonard Sank | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Dec 2007 | 85,000 | 3,345,000 | - | - | Common Stock | |
| Leonard Sank | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Dec 2007 | 121,160 | 3,466,160 | - | - | Common Stock | |
| Miriam Kidron | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2007 | 850,000 | 850,000 | - | - | stock options | |
| Kidron Nadav | Director, President & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2007 | 850,000 | 850,000 | - | - | stock options | |
| Young Michael | Other | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 27 May 2004 | 6,000,000 | 0 | - | - | Common Stock |